Black Diamond Therapeutics, Inc.
- BDTX
- NASDAQ
- Biotechnology
- Precision Oncology
- Targeted Cancer Therapy
- Small-Molecule Inhibitors
$1.72
Today −1.15%Quote Oct 16, 2026, 08:00 PM UTC
−10.88%over the last month
Max drawdown −15.2%From 1-month high −13.1%3 months −5.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$98.6M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$11.83
+587.8% from here
Floor
$1.69
1.7% below price
Where the price sits
11 analysts
Analyst range, low to high
$8.00$20.00
- Price $1.72
- Resistance $1.75
- Consensus $11.83
The price is just above its floor and right under resistance. Analysts' average target sits about 588% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BDTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
21